ArticleAnnals of translational medicine2015

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.

Fabian Lohaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.